Optical coherence tomography biomarkers as outcome predictors to guide dexamethasone implant use in patients with iERM: a randomized controlled trial.

Rong LuanManqiao WangYi GongBoshi LiuXinyuan HuangJie WangShuo SunJinzhi ZhaoXiteng ChenQianhui YangJuping LiuYan ShaoXiao-Rong Li

Published in: BMC ophthalmology (2024)

The trail has been registered at Chinese Clinical Trail Registry( https://www.chictr.org.cn ) on 2021/03/12 (ChiCTR2100044228). And all patients in the article were enrolled after registration.

Keyphrases

end stage renal disease
optical coherence tomography
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
low dose
high dose
squamous cell carcinoma
lymph node metastasis
patient reported outcomes
soft tissue
patient reported